Yanlin Lv
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yanlin Lv has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Guanghui Ma
State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, People’s Republic of China
2 shared publications - Wei Wei
State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, People’s Republic of China
2 shared publications - Weier Bao
School of Chemical Sciences
2 shared publications - Zhiyuan Tian
School of Chemical Sciences, University of Chinese Academy of Sciences (UCAS), Beijing, 100049, China
2 shared publications - Feng Li
State Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China
1 shared publication Guihong Lu
State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, P. R. China
1 shared publication
Latest Publications
- Open Access
- 26 July 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-17
Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation
The therapeutic efficacy of whole tumor cell vaccines (TCVs) is modest, which has delayed their translation into personalized immunotherapies in the clinic. Here, we develop a TCV platform based on photothermal nanoparticle-loaded tumor cells, which can be rationally applied to diverse tumor types to achieve on-demand boost of anti-tumor immune responses for inhibiting tumor growth. During the fabrication process, mild photothermal heating by near-infrared (NIR) laser irradiation induces the nanoparticle-bearing tumor cells to express heat shock proteins as endogenous adjuvants. After a single vaccination at the back of tumor-bearing mice, non-invasive NIR laser irradiation further induces mild hyperthermia at vaccination site, which promotes the recruitment, activation, and antigen presentation by dendritic cells. Using an indicator we term fluctuation of tumor growth rate, we determine appropriate irradiation regimens (including optimized irradiation intervals and times). This TCV platform enables on-demand NIR manipulation of immune responses, and we demonstrate potent therapeutic efficacy against six murine models that mimick a range of clinical scenarios, including a model based on humanized mice and patient-derived tumor xenografts.
- 26 July 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-17
Open AccessGeneration of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation
The therapeutic efficacy of whole tumor cell vaccines (TCVs) is modest, which has delayed their translation into personalized immunotherapies in the clinic. Here, we develop a TCV platform based on photothermal nanoparticle-loaded tumor cells, which can be rationally applied to diverse tumor types to achieve on-demand boost of anti-tumor immune responses for inhibiting tumor growth. During the fabrication process, mild photothermal heating by near-infrared (NIR) laser irradiation induces the nanoparticle-bearing tumor cells to express heat shock proteins as endogenous adjuvants. After a single vaccination at the back of tumor-bearing mice, non-invasive NIR laser irradiation further induces mild hyperthermia at vaccination site, which promotes the recruitment, activation, and antigen presentation by dendritic cells. Using an indicator we term fluctuation of tumor growth rate, we determine appropriate irradiation regimens (including optimized irradiation intervals and times). This TCV platform enables on-demand NIR manipulation of immune responses, and we demonstrate potent therapeutic efficacy against six murine models that mimick a range of clinical scenarios, including a model based on humanized mice and patient-derived tumor xenografts.
- Top Cited PapersOpen Access
- 26 March 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (13) , eabd7614
Near-infrared light–triggered platelet arsenal for combined photothermal-immunotherapy against cancer
The aggregative instinct of platelets was exploited as a biomimetic strategy for synergistic combined therapy against cancer.
- 26 March 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (13) , eabd7614
Top Cited PapersOpen AccessNear-infrared light–triggered platelet arsenal for combined photothermal-immunotherapy against cancer
The aggregative instinct of platelets was exploited as a biomimetic strategy for synergistic combined therapy against cancer.